ArticleCancer medicine2026
Characterizing the Objective Time Spent on Health Care Activities in Clinic and at Home for Patients With Cancer.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundWhile the time burden of cancer care is increasingly recognized in oncology, existing research lacks the granularity needed to identify intervention targets. This study characterized time spent on cancer care at home and in-clinic, including travel, waiting, and clinical tasks, assessing variations by treatment modality.
methodsWe conducted a secondary analysis of two longitudinal cohorts. Cohort 1 included patients with metastatic breast or advanced ovarian cancer (n = 55) and Cohort 2 included patients with any cancer (n = 55) receiving systemic anti-cancer therapy. Participants used a mobile application for 28 days that collected GPS and motion sensor data to infer locations. Daily surveys characterized activities and captured time spent on home-based tasks.
resultsThe study population (N = 110) was predominantly female and White, receiving a mix of infusion and oral treatments. Participants recorded 597 out-of-home healthcare episodes. While median time receiving care per episode for lab-only visits was short (10 min), visits combining labs and treatment had a median duration of 162 min (compared to treatment alone, median duration of 68 min). Patients on infusion therapies experienced higher time burdens per episode both in-facility (median 125 min vs. 50 min for oral therapy) and at home for scheduling and symptom management (median 188 min vs. 102 min).
conclusionsPatients face substantial time burdens that extend beyond the clinical encounter. Waiting between stages, such as labs and treatment, makes combined out-of-home healthcare episodes disproportionately time-consuming. These data facilitate a deeper understanding of the trade-offs between different treatment modalities and care delivery models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.